Treatment of Angina Flashcards
Angina
- definition
- treatment
Angina - chest pain caused by reduced blood flow to heart muscles
Treatment:
increase delivery of 02 or decrease 02 demand
Determinants of the volume of O2 required by the heart
- Diastolic factors: blood volume and venous tone
2. Systolic factors: peripheral resistance, heart rate, heart force, ejection time
Agents used in angina
- Organic nitrates (nitroglycerin)
- Calcium antagonists
- B adrenoreceptors antagonists
Organic nitrates (nitroglycerin) -mechanism of action (7)
- Nitroglycerin is converted to Nitric oxide
- NO activates guanylate cyclase
- cGMP synthesis is increased
- Activate protein kinase dependent phosphorylation in smooth muscle
- Dephosphorylation of myosin light chain in smooth muscle
- Decrease preload and wall tension, increase collateral vessel diameter
- Decrease work in the heart, decrease BP = relief angina
Mechanism of the interaction between nitrates and drugs used in erectile dysfunction
-SILDENAFIL - phosphodiesterase-5-inhibitor
- reduce cGMP metabolism
- synergistic effect on blood pressure resulting in dangerous hypotension
Indications: erectile dysfunction, pulmonary hypertension
Nitrates
-names
NITROGLYCERIN (GLYCERYL TRINITRATE)
ISOSORBIDE MONONITRATE
Nitroglycerin
-pharmacokinetics (6)
- liver –> removes nitrate groups from the parent molecule and ultimately inactivates the drug
- oral bioavailability is low
- sublingual route –> avoid first pass effect
- excretion via kidney in the form of glucuronide derivatives
- may loose potency when stored as a result of volatilization, should be kept in glass containers
- short onset and duration of action
Nitroglycerin
-pharmacodynamics
- must be bio-activated with the release of NO
- Activation requires –> denitrated by glutathione-S-transferase (in smooth muscle and other cells), mitochondrial enzyme, aldehydre dehydrogenase isoform 2 and 3 (release NO)
- NO activate guanylyl cyclase
- increase cGMP
- activates protein kinase G
- decrease activity of contractile proteins and intracellular Ca2+
Nitroglycerin
-actions on vascular smooth muscle (4)
- response on veins at lower concentrations than in arteries
- large arteries and large veins relax
- cardiac ouput decrease
- pulmonary vascular pressure and heart size are reduced
Nitroglycerin
- actions on platelets
- other effects
- contraindications
- decrease cGMP –> decrease platelet aggregation
- nitrite ion reacts with hemoglobin –> produce methemoglobin (low affinity for O2)
- intracranial pressure is elevated
Nitroglycerin
- unwanted effects
- tolerance
- orthostatic hypotension, tachycardia, headache
- very large doses –> pseudocyanosis, tissue hypoxia, death
- occurs with continuous exposure
- decrease in tissue cysteine, systemic compensation (sympathetic discharge and retention of salt)
- supplementation of cysteine may partially reverse tolerance
- nitrate free period of at least 8h between doses to reduce or prevent tolerance
Nitrates
-indications (4)
- stable angina –> isosorbide monitrate (oral), nitroglycerin (oral prolonged, sublingual before exertion)
- unstable angina –> nitroglycerin (intravenous)
- acute heart failure –> nitroglycerin (intravenous)
- chronic heart failure –> isosorbide monitrate (oral)
B adrenoreceptors antagonists
- names and function
- effects
Propranolol –> both beta 1 and 2 antagonism
Metoprolol –> b1 selective blocker
Labetolol –> mixed antagonism of both beta and alpha-1 adrenergic receptors, both beta 1 and 2 antagonism, intrinsic sympathomimetic action (ISA), could cause additional vasodilation
Nebivolol –> vasodilation action via NO and b3 stimulating effects, b1 selective blockers
-decrease heart rate and contractility
Intrinsic sympathomimetic action (ISA) (5)
- both agonism and antagonism at a given beta receptor
- depends on the concentration of the beta blocker and the concentration of the antagonized agent
- labetolol exhibit it
- useful in individuals exhibiting excessive bradycardia
- not used after MI, may be less effective than others in the treatment of angina and tachyarrhythmia
Beta blockers
- indications
- unwanted effects
- arrhythmias, angina, MI, hypertension, heart failure, glaucoma, anxiety, migraine
- bronchoconstriction, cardiac depression, bradycardia, hypoglycemia, fatigue, cold extremities